Women With COVID-19 May Have More Post-Birth Complications, New Study Suggests 23/10/2020 Raisa Santos A milestone study has found that women giving birth when they are infected with COVID-19, even if asymptomatic, may have more post-birth complications, including fever and hypoxia leading to hospital readmission, as compared to women who are not infected. The study, conducted by Malavika Rabhu of Weill Cornell Medicine, observed 675 women admitted for delivery […] Continue reading -> Harnessing COVID-19 Innovations Could Revolutionize TB Care 23/10/2020 Madeleine Hoecklin In combatting COVID-19, many countries around the world are currently facing “house on fire moments,” as described by Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota. However, the syndemic of COVID-19 and TB poses an even more deadly threat. TB and COVID-19 respiratory diseases affect mostly […] Continue reading -> Resistance To COVID-19 Vaccine Running So High It Would Twart Efforts To Reach Community Immunity – New Study 20/10/2020 Madeleine Hoecklin Current levels of public reluctance to be immunized with a forthcoming COVID-19 vaccine are so high that the resistance would in fact pre-empt many countries from reaching sufficient levels of “community” immunity, according to a new study of vaccine hesitancy among people in 19 of the most COVID-impacted countries around the world. The study of […] Continue reading -> US Has Experienced Highest COVID-19 Mortality Rates Among 18 OECD Countries 19/10/2020 Madeleine Hoecklin Along with recording the most deaths from COVID-19 of any country in the world, the US has ranked highest among leading OECD countries in deaths per capita from the infectious disease, according to a recent study published in the Journal of the American Medical Association (JAMA) by researchers from Harvard University and the University of […] Continue reading -> WHO Releases a Position Statement on Genetically Modified Mosquitoes for the Control of Vector-Borne Diseases 19/10/2020 Elaine Ruth Fletcher Genetically modified mosquitoes could be an innovative tool to combat vector-borne diseases and eliminate malaria, says a new WHO position statement. Genetically modified mosquitoes are designed to suppress mosquito populations and reduce their susceptibility to infection and their ability to transmit disease-carrying pathogens. WHO announced their support for the continued investigation into genetically modified mosquitoes as […] Continue reading -> Pfizer Won’t Pursue Emergency Authorization for COVID-19 Vaccine Before Mid-November, Says CEO in Open Letter 16/10/2020 Madeleine Hoecklin Pfizer CEO, Albert Bourla, announced Friday in an open letter that the pharmaceutical company developing a COVID-19 vaccine will not request an emergency authorization before mid-November – meaning that the file of the vaccine candidate that is regarded as the front-runner in the global race to get a vaccine to market would only be reviewed […] Continue reading -> China’s Inactivated COVID-19 Vaccine Candidate Is Safe and Provokes Immune Response, Say Preliminary Clinical Trial Results 16/10/2020 Madeleine Hoecklin A new study published in The Lancet on Thursday found that an inactivated vaccine candidate, called BBIBP-CorV, was safe and provoked an immune response in healthy individuals. This is the first study of an inactivated COVID-19 vaccine to include participants over 60 years of age. The BBIBP-CorV vaccine is being developed by the Beijing Institute of […] Continue reading -> First Case Of COVID-19 Reinfection In The US Confirmed; Exposure to Virus May Not Guarantee Protective Immunity, Says New Lancet Study 13/10/2020 Madeleine Hoecklin A study confirming the first case of a person reinfected with COVID-19 in the US and the fifth such confirmed case of reinfection worldwide was published in The Lancet Infectious Diseases journal on Monday. The findings suggest that protected immunity conferred by infection with SARS-CoV2 – a phenomenon that is not well understood yet – […] Continue reading -> Neurological Symptoms and Brain Disorders Upend Recovery Of Significant Numbers Of COVID-19 Survivors 12/10/2020 Madeleine Hoecklin Cognitive symptoms are being reported by thousands of COVID-19 survivors, even those with mild symptoms and no previous medical conditions. The symptoms often include memory loss, confusion, difficulty focusing, and dizziness. A study published just last week covering more than 500 hospitalized patients in Chicago, found that some 82% had experienced neurological symptoms at some point […] Continue reading -> Two Million Stillbirths Occur Annually; Pandemic Add To Risks In Coming Year, Says First UN Report On The Neglected Issue 08/10/2020 Madeleine Hoecklin One stillbirth occurs every 16 seconds worldwide with approximately 2 million stillborn babies a year, says the first UN-wide report to document the global scale of the issue. And COVID-19 related interruptions in maternal and child care services, particularly emergency obstetric care, could lead to an additional 60,000 to 200,000 stillbirths over the next 12 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Harnessing COVID-19 Innovations Could Revolutionize TB Care 23/10/2020 Madeleine Hoecklin In combatting COVID-19, many countries around the world are currently facing “house on fire moments,” as described by Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota. However, the syndemic of COVID-19 and TB poses an even more deadly threat. TB and COVID-19 respiratory diseases affect mostly […] Continue reading -> Resistance To COVID-19 Vaccine Running So High It Would Twart Efforts To Reach Community Immunity – New Study 20/10/2020 Madeleine Hoecklin Current levels of public reluctance to be immunized with a forthcoming COVID-19 vaccine are so high that the resistance would in fact pre-empt many countries from reaching sufficient levels of “community” immunity, according to a new study of vaccine hesitancy among people in 19 of the most COVID-impacted countries around the world. The study of […] Continue reading -> US Has Experienced Highest COVID-19 Mortality Rates Among 18 OECD Countries 19/10/2020 Madeleine Hoecklin Along with recording the most deaths from COVID-19 of any country in the world, the US has ranked highest among leading OECD countries in deaths per capita from the infectious disease, according to a recent study published in the Journal of the American Medical Association (JAMA) by researchers from Harvard University and the University of […] Continue reading -> WHO Releases a Position Statement on Genetically Modified Mosquitoes for the Control of Vector-Borne Diseases 19/10/2020 Elaine Ruth Fletcher Genetically modified mosquitoes could be an innovative tool to combat vector-borne diseases and eliminate malaria, says a new WHO position statement. Genetically modified mosquitoes are designed to suppress mosquito populations and reduce their susceptibility to infection and their ability to transmit disease-carrying pathogens. WHO announced their support for the continued investigation into genetically modified mosquitoes as […] Continue reading -> Pfizer Won’t Pursue Emergency Authorization for COVID-19 Vaccine Before Mid-November, Says CEO in Open Letter 16/10/2020 Madeleine Hoecklin Pfizer CEO, Albert Bourla, announced Friday in an open letter that the pharmaceutical company developing a COVID-19 vaccine will not request an emergency authorization before mid-November – meaning that the file of the vaccine candidate that is regarded as the front-runner in the global race to get a vaccine to market would only be reviewed […] Continue reading -> China’s Inactivated COVID-19 Vaccine Candidate Is Safe and Provokes Immune Response, Say Preliminary Clinical Trial Results 16/10/2020 Madeleine Hoecklin A new study published in The Lancet on Thursday found that an inactivated vaccine candidate, called BBIBP-CorV, was safe and provoked an immune response in healthy individuals. This is the first study of an inactivated COVID-19 vaccine to include participants over 60 years of age. The BBIBP-CorV vaccine is being developed by the Beijing Institute of […] Continue reading -> First Case Of COVID-19 Reinfection In The US Confirmed; Exposure to Virus May Not Guarantee Protective Immunity, Says New Lancet Study 13/10/2020 Madeleine Hoecklin A study confirming the first case of a person reinfected with COVID-19 in the US and the fifth such confirmed case of reinfection worldwide was published in The Lancet Infectious Diseases journal on Monday. The findings suggest that protected immunity conferred by infection with SARS-CoV2 – a phenomenon that is not well understood yet – […] Continue reading -> Neurological Symptoms and Brain Disorders Upend Recovery Of Significant Numbers Of COVID-19 Survivors 12/10/2020 Madeleine Hoecklin Cognitive symptoms are being reported by thousands of COVID-19 survivors, even those with mild symptoms and no previous medical conditions. The symptoms often include memory loss, confusion, difficulty focusing, and dizziness. A study published just last week covering more than 500 hospitalized patients in Chicago, found that some 82% had experienced neurological symptoms at some point […] Continue reading -> Two Million Stillbirths Occur Annually; Pandemic Add To Risks In Coming Year, Says First UN Report On The Neglected Issue 08/10/2020 Madeleine Hoecklin One stillbirth occurs every 16 seconds worldwide with approximately 2 million stillborn babies a year, says the first UN-wide report to document the global scale of the issue. And COVID-19 related interruptions in maternal and child care services, particularly emergency obstetric care, could lead to an additional 60,000 to 200,000 stillbirths over the next 12 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Resistance To COVID-19 Vaccine Running So High It Would Twart Efforts To Reach Community Immunity – New Study 20/10/2020 Madeleine Hoecklin Current levels of public reluctance to be immunized with a forthcoming COVID-19 vaccine are so high that the resistance would in fact pre-empt many countries from reaching sufficient levels of “community” immunity, according to a new study of vaccine hesitancy among people in 19 of the most COVID-impacted countries around the world. The study of […] Continue reading -> US Has Experienced Highest COVID-19 Mortality Rates Among 18 OECD Countries 19/10/2020 Madeleine Hoecklin Along with recording the most deaths from COVID-19 of any country in the world, the US has ranked highest among leading OECD countries in deaths per capita from the infectious disease, according to a recent study published in the Journal of the American Medical Association (JAMA) by researchers from Harvard University and the University of […] Continue reading -> WHO Releases a Position Statement on Genetically Modified Mosquitoes for the Control of Vector-Borne Diseases 19/10/2020 Elaine Ruth Fletcher Genetically modified mosquitoes could be an innovative tool to combat vector-borne diseases and eliminate malaria, says a new WHO position statement. Genetically modified mosquitoes are designed to suppress mosquito populations and reduce their susceptibility to infection and their ability to transmit disease-carrying pathogens. WHO announced their support for the continued investigation into genetically modified mosquitoes as […] Continue reading -> Pfizer Won’t Pursue Emergency Authorization for COVID-19 Vaccine Before Mid-November, Says CEO in Open Letter 16/10/2020 Madeleine Hoecklin Pfizer CEO, Albert Bourla, announced Friday in an open letter that the pharmaceutical company developing a COVID-19 vaccine will not request an emergency authorization before mid-November – meaning that the file of the vaccine candidate that is regarded as the front-runner in the global race to get a vaccine to market would only be reviewed […] Continue reading -> China’s Inactivated COVID-19 Vaccine Candidate Is Safe and Provokes Immune Response, Say Preliminary Clinical Trial Results 16/10/2020 Madeleine Hoecklin A new study published in The Lancet on Thursday found that an inactivated vaccine candidate, called BBIBP-CorV, was safe and provoked an immune response in healthy individuals. This is the first study of an inactivated COVID-19 vaccine to include participants over 60 years of age. The BBIBP-CorV vaccine is being developed by the Beijing Institute of […] Continue reading -> First Case Of COVID-19 Reinfection In The US Confirmed; Exposure to Virus May Not Guarantee Protective Immunity, Says New Lancet Study 13/10/2020 Madeleine Hoecklin A study confirming the first case of a person reinfected with COVID-19 in the US and the fifth such confirmed case of reinfection worldwide was published in The Lancet Infectious Diseases journal on Monday. The findings suggest that protected immunity conferred by infection with SARS-CoV2 – a phenomenon that is not well understood yet – […] Continue reading -> Neurological Symptoms and Brain Disorders Upend Recovery Of Significant Numbers Of COVID-19 Survivors 12/10/2020 Madeleine Hoecklin Cognitive symptoms are being reported by thousands of COVID-19 survivors, even those with mild symptoms and no previous medical conditions. The symptoms often include memory loss, confusion, difficulty focusing, and dizziness. A study published just last week covering more than 500 hospitalized patients in Chicago, found that some 82% had experienced neurological symptoms at some point […] Continue reading -> Two Million Stillbirths Occur Annually; Pandemic Add To Risks In Coming Year, Says First UN Report On The Neglected Issue 08/10/2020 Madeleine Hoecklin One stillbirth occurs every 16 seconds worldwide with approximately 2 million stillborn babies a year, says the first UN-wide report to document the global scale of the issue. And COVID-19 related interruptions in maternal and child care services, particularly emergency obstetric care, could lead to an additional 60,000 to 200,000 stillbirths over the next 12 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
US Has Experienced Highest COVID-19 Mortality Rates Among 18 OECD Countries 19/10/2020 Madeleine Hoecklin Along with recording the most deaths from COVID-19 of any country in the world, the US has ranked highest among leading OECD countries in deaths per capita from the infectious disease, according to a recent study published in the Journal of the American Medical Association (JAMA) by researchers from Harvard University and the University of […] Continue reading -> WHO Releases a Position Statement on Genetically Modified Mosquitoes for the Control of Vector-Borne Diseases 19/10/2020 Elaine Ruth Fletcher Genetically modified mosquitoes could be an innovative tool to combat vector-borne diseases and eliminate malaria, says a new WHO position statement. Genetically modified mosquitoes are designed to suppress mosquito populations and reduce their susceptibility to infection and their ability to transmit disease-carrying pathogens. WHO announced their support for the continued investigation into genetically modified mosquitoes as […] Continue reading -> Pfizer Won’t Pursue Emergency Authorization for COVID-19 Vaccine Before Mid-November, Says CEO in Open Letter 16/10/2020 Madeleine Hoecklin Pfizer CEO, Albert Bourla, announced Friday in an open letter that the pharmaceutical company developing a COVID-19 vaccine will not request an emergency authorization before mid-November – meaning that the file of the vaccine candidate that is regarded as the front-runner in the global race to get a vaccine to market would only be reviewed […] Continue reading -> China’s Inactivated COVID-19 Vaccine Candidate Is Safe and Provokes Immune Response, Say Preliminary Clinical Trial Results 16/10/2020 Madeleine Hoecklin A new study published in The Lancet on Thursday found that an inactivated vaccine candidate, called BBIBP-CorV, was safe and provoked an immune response in healthy individuals. This is the first study of an inactivated COVID-19 vaccine to include participants over 60 years of age. The BBIBP-CorV vaccine is being developed by the Beijing Institute of […] Continue reading -> First Case Of COVID-19 Reinfection In The US Confirmed; Exposure to Virus May Not Guarantee Protective Immunity, Says New Lancet Study 13/10/2020 Madeleine Hoecklin A study confirming the first case of a person reinfected with COVID-19 in the US and the fifth such confirmed case of reinfection worldwide was published in The Lancet Infectious Diseases journal on Monday. The findings suggest that protected immunity conferred by infection with SARS-CoV2 – a phenomenon that is not well understood yet – […] Continue reading -> Neurological Symptoms and Brain Disorders Upend Recovery Of Significant Numbers Of COVID-19 Survivors 12/10/2020 Madeleine Hoecklin Cognitive symptoms are being reported by thousands of COVID-19 survivors, even those with mild symptoms and no previous medical conditions. The symptoms often include memory loss, confusion, difficulty focusing, and dizziness. A study published just last week covering more than 500 hospitalized patients in Chicago, found that some 82% had experienced neurological symptoms at some point […] Continue reading -> Two Million Stillbirths Occur Annually; Pandemic Add To Risks In Coming Year, Says First UN Report On The Neglected Issue 08/10/2020 Madeleine Hoecklin One stillbirth occurs every 16 seconds worldwide with approximately 2 million stillborn babies a year, says the first UN-wide report to document the global scale of the issue. And COVID-19 related interruptions in maternal and child care services, particularly emergency obstetric care, could lead to an additional 60,000 to 200,000 stillbirths over the next 12 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Releases a Position Statement on Genetically Modified Mosquitoes for the Control of Vector-Borne Diseases 19/10/2020 Elaine Ruth Fletcher Genetically modified mosquitoes could be an innovative tool to combat vector-borne diseases and eliminate malaria, says a new WHO position statement. Genetically modified mosquitoes are designed to suppress mosquito populations and reduce their susceptibility to infection and their ability to transmit disease-carrying pathogens. WHO announced their support for the continued investigation into genetically modified mosquitoes as […] Continue reading -> Pfizer Won’t Pursue Emergency Authorization for COVID-19 Vaccine Before Mid-November, Says CEO in Open Letter 16/10/2020 Madeleine Hoecklin Pfizer CEO, Albert Bourla, announced Friday in an open letter that the pharmaceutical company developing a COVID-19 vaccine will not request an emergency authorization before mid-November – meaning that the file of the vaccine candidate that is regarded as the front-runner in the global race to get a vaccine to market would only be reviewed […] Continue reading -> China’s Inactivated COVID-19 Vaccine Candidate Is Safe and Provokes Immune Response, Say Preliminary Clinical Trial Results 16/10/2020 Madeleine Hoecklin A new study published in The Lancet on Thursday found that an inactivated vaccine candidate, called BBIBP-CorV, was safe and provoked an immune response in healthy individuals. This is the first study of an inactivated COVID-19 vaccine to include participants over 60 years of age. The BBIBP-CorV vaccine is being developed by the Beijing Institute of […] Continue reading -> First Case Of COVID-19 Reinfection In The US Confirmed; Exposure to Virus May Not Guarantee Protective Immunity, Says New Lancet Study 13/10/2020 Madeleine Hoecklin A study confirming the first case of a person reinfected with COVID-19 in the US and the fifth such confirmed case of reinfection worldwide was published in The Lancet Infectious Diseases journal on Monday. The findings suggest that protected immunity conferred by infection with SARS-CoV2 – a phenomenon that is not well understood yet – […] Continue reading -> Neurological Symptoms and Brain Disorders Upend Recovery Of Significant Numbers Of COVID-19 Survivors 12/10/2020 Madeleine Hoecklin Cognitive symptoms are being reported by thousands of COVID-19 survivors, even those with mild symptoms and no previous medical conditions. The symptoms often include memory loss, confusion, difficulty focusing, and dizziness. A study published just last week covering more than 500 hospitalized patients in Chicago, found that some 82% had experienced neurological symptoms at some point […] Continue reading -> Two Million Stillbirths Occur Annually; Pandemic Add To Risks In Coming Year, Says First UN Report On The Neglected Issue 08/10/2020 Madeleine Hoecklin One stillbirth occurs every 16 seconds worldwide with approximately 2 million stillborn babies a year, says the first UN-wide report to document the global scale of the issue. And COVID-19 related interruptions in maternal and child care services, particularly emergency obstetric care, could lead to an additional 60,000 to 200,000 stillbirths over the next 12 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Pfizer Won’t Pursue Emergency Authorization for COVID-19 Vaccine Before Mid-November, Says CEO in Open Letter 16/10/2020 Madeleine Hoecklin Pfizer CEO, Albert Bourla, announced Friday in an open letter that the pharmaceutical company developing a COVID-19 vaccine will not request an emergency authorization before mid-November – meaning that the file of the vaccine candidate that is regarded as the front-runner in the global race to get a vaccine to market would only be reviewed […] Continue reading -> China’s Inactivated COVID-19 Vaccine Candidate Is Safe and Provokes Immune Response, Say Preliminary Clinical Trial Results 16/10/2020 Madeleine Hoecklin A new study published in The Lancet on Thursday found that an inactivated vaccine candidate, called BBIBP-CorV, was safe and provoked an immune response in healthy individuals. This is the first study of an inactivated COVID-19 vaccine to include participants over 60 years of age. The BBIBP-CorV vaccine is being developed by the Beijing Institute of […] Continue reading -> First Case Of COVID-19 Reinfection In The US Confirmed; Exposure to Virus May Not Guarantee Protective Immunity, Says New Lancet Study 13/10/2020 Madeleine Hoecklin A study confirming the first case of a person reinfected with COVID-19 in the US and the fifth such confirmed case of reinfection worldwide was published in The Lancet Infectious Diseases journal on Monday. The findings suggest that protected immunity conferred by infection with SARS-CoV2 – a phenomenon that is not well understood yet – […] Continue reading -> Neurological Symptoms and Brain Disorders Upend Recovery Of Significant Numbers Of COVID-19 Survivors 12/10/2020 Madeleine Hoecklin Cognitive symptoms are being reported by thousands of COVID-19 survivors, even those with mild symptoms and no previous medical conditions. The symptoms often include memory loss, confusion, difficulty focusing, and dizziness. A study published just last week covering more than 500 hospitalized patients in Chicago, found that some 82% had experienced neurological symptoms at some point […] Continue reading -> Two Million Stillbirths Occur Annually; Pandemic Add To Risks In Coming Year, Says First UN Report On The Neglected Issue 08/10/2020 Madeleine Hoecklin One stillbirth occurs every 16 seconds worldwide with approximately 2 million stillborn babies a year, says the first UN-wide report to document the global scale of the issue. And COVID-19 related interruptions in maternal and child care services, particularly emergency obstetric care, could lead to an additional 60,000 to 200,000 stillbirths over the next 12 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
China’s Inactivated COVID-19 Vaccine Candidate Is Safe and Provokes Immune Response, Say Preliminary Clinical Trial Results 16/10/2020 Madeleine Hoecklin A new study published in The Lancet on Thursday found that an inactivated vaccine candidate, called BBIBP-CorV, was safe and provoked an immune response in healthy individuals. This is the first study of an inactivated COVID-19 vaccine to include participants over 60 years of age. The BBIBP-CorV vaccine is being developed by the Beijing Institute of […] Continue reading -> First Case Of COVID-19 Reinfection In The US Confirmed; Exposure to Virus May Not Guarantee Protective Immunity, Says New Lancet Study 13/10/2020 Madeleine Hoecklin A study confirming the first case of a person reinfected with COVID-19 in the US and the fifth such confirmed case of reinfection worldwide was published in The Lancet Infectious Diseases journal on Monday. The findings suggest that protected immunity conferred by infection with SARS-CoV2 – a phenomenon that is not well understood yet – […] Continue reading -> Neurological Symptoms and Brain Disorders Upend Recovery Of Significant Numbers Of COVID-19 Survivors 12/10/2020 Madeleine Hoecklin Cognitive symptoms are being reported by thousands of COVID-19 survivors, even those with mild symptoms and no previous medical conditions. The symptoms often include memory loss, confusion, difficulty focusing, and dizziness. A study published just last week covering more than 500 hospitalized patients in Chicago, found that some 82% had experienced neurological symptoms at some point […] Continue reading -> Two Million Stillbirths Occur Annually; Pandemic Add To Risks In Coming Year, Says First UN Report On The Neglected Issue 08/10/2020 Madeleine Hoecklin One stillbirth occurs every 16 seconds worldwide with approximately 2 million stillborn babies a year, says the first UN-wide report to document the global scale of the issue. And COVID-19 related interruptions in maternal and child care services, particularly emergency obstetric care, could lead to an additional 60,000 to 200,000 stillbirths over the next 12 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
First Case Of COVID-19 Reinfection In The US Confirmed; Exposure to Virus May Not Guarantee Protective Immunity, Says New Lancet Study 13/10/2020 Madeleine Hoecklin A study confirming the first case of a person reinfected with COVID-19 in the US and the fifth such confirmed case of reinfection worldwide was published in The Lancet Infectious Diseases journal on Monday. The findings suggest that protected immunity conferred by infection with SARS-CoV2 – a phenomenon that is not well understood yet – […] Continue reading -> Neurological Symptoms and Brain Disorders Upend Recovery Of Significant Numbers Of COVID-19 Survivors 12/10/2020 Madeleine Hoecklin Cognitive symptoms are being reported by thousands of COVID-19 survivors, even those with mild symptoms and no previous medical conditions. The symptoms often include memory loss, confusion, difficulty focusing, and dizziness. A study published just last week covering more than 500 hospitalized patients in Chicago, found that some 82% had experienced neurological symptoms at some point […] Continue reading -> Two Million Stillbirths Occur Annually; Pandemic Add To Risks In Coming Year, Says First UN Report On The Neglected Issue 08/10/2020 Madeleine Hoecklin One stillbirth occurs every 16 seconds worldwide with approximately 2 million stillborn babies a year, says the first UN-wide report to document the global scale of the issue. And COVID-19 related interruptions in maternal and child care services, particularly emergency obstetric care, could lead to an additional 60,000 to 200,000 stillbirths over the next 12 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Neurological Symptoms and Brain Disorders Upend Recovery Of Significant Numbers Of COVID-19 Survivors 12/10/2020 Madeleine Hoecklin Cognitive symptoms are being reported by thousands of COVID-19 survivors, even those with mild symptoms and no previous medical conditions. The symptoms often include memory loss, confusion, difficulty focusing, and dizziness. A study published just last week covering more than 500 hospitalized patients in Chicago, found that some 82% had experienced neurological symptoms at some point […] Continue reading -> Two Million Stillbirths Occur Annually; Pandemic Add To Risks In Coming Year, Says First UN Report On The Neglected Issue 08/10/2020 Madeleine Hoecklin One stillbirth occurs every 16 seconds worldwide with approximately 2 million stillborn babies a year, says the first UN-wide report to document the global scale of the issue. And COVID-19 related interruptions in maternal and child care services, particularly emergency obstetric care, could lead to an additional 60,000 to 200,000 stillbirths over the next 12 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Two Million Stillbirths Occur Annually; Pandemic Add To Risks In Coming Year, Says First UN Report On The Neglected Issue 08/10/2020 Madeleine Hoecklin One stillbirth occurs every 16 seconds worldwide with approximately 2 million stillborn babies a year, says the first UN-wide report to document the global scale of the issue. And COVID-19 related interruptions in maternal and child care services, particularly emergency obstetric care, could lead to an additional 60,000 to 200,000 stillbirths over the next 12 […] Continue reading -> Posts navigation Older posts